Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A is a subtype of autosomal recessive intermediate Charcot-Marie-Tooth (CMT) disease characterized by severe, early childhood-onset CMT neuropathy with prominent pes equinovarus deformity and impairment of hand muscles. Nerve conduction velocities usually range between 25-35 m/s and both axonal and demyelinating changes are observed on peripheral nerve pathology.
Features include always present findings: Distal sensory impairment, Hyporeflexia, Decreased number of large peripheral myelinated nerve fibers, and Onion bulb formation and others; and common findings: Fiber type grouping, Angulated muscle fibers, Lower limb muscle weakness, and Type 1 muscle fiber predominance and others. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 6 | Limb muscle weakness, Angulated muscle fibers, Lower limb muscle weakness |
Brain and nerves | 4 | Steppage gait, Hyporeflexia, EMG: neuropathic changes |
Arms and legs | 4 | Limb muscle weakness, Lower limb muscle weakness, Foot dorsiflexor weakness |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
GDAP1 encodes ganglioside induced differentiation associated protein 1 (358 aa). Regulates the mitochondrial network by promoting mitochondrial fission Highest expression in Brain Cerebellar Hemisphere (80.1 TPM) and Brain Frontal Cortex BA9 (56.7 TPM).
Charcot-Marie-Tooth disease recessive intermediate A is associated with mutations in the GDAP1 gene on chromosome 8.
The GDAP1 protein participates in Class I Peroxisomal Membrane Proteins pathway.
GDAP1 is classified as a druggable target with score 0.0.
Genetic testing for GDAP1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Charcot-Marie-Tooth disease recessive intermediate A.
8 publications have been identified in PubMed for Charcot-Marie-Tooth disease recessive intermediate A. Research spans Basic Science / Preclinical (38%), Epidemiology / Natural History (38%), and Case Report / Case Series (25%).
Vidon RO (2026). [PMID: 41562385](https://pubmed.ncbi.nlm.nih.gov/41562385/). *J Peripher Nerv Syst*. [Case Report / Case Series]
Cortese A (2025). [PMID: 39938083](https://pubmed.ncbi.nlm.nih.gov/39938083/). *Brain*. [Epidemiology / Natural History]
Zhang L (2025). [PMID: 40618856](https://pubmed.ncbi.nlm.nih.gov/40618856/). *Neurobiol Dis*. [Basic Science / Preclinical]
Cakar A (2025). [PMID: 39776111](https://pubmed.ncbi.nlm.nih.gov/39776111/). *Eur J Neurol*. [Epidemiology / Natural History]
Borisova NR (2025). [PMID: 41354077](https://pubmed.ncbi.nlm.nih.gov/41354077/). *Biochemistry (Mosc)*. [Case Report / Case Series]
Ferreira T (2024). [PMID: 38549004](https://pubmed.ncbi.nlm.nih.gov/38549004/). *J Neurol*. [Basic Science / Preclinical]
Arlt A (2024). [PMID: 38975976](https://pubmed.ncbi.nlm.nih.gov/38975976/). *J Neurogenet*. [Epidemiology / Natural History]
Ceprian M (2024). [PMID: 38673950](https://pubmed.ncbi.nlm.nih.gov/38673950/). *Int J Mol Sci*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease recessive intermediate A